Raymond James Financial
TNDM icon

Raymond James Financial’s Tandem Diabetes Care TNDM Stock Holding History

Raymond James Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Buy
125,345
+5,176
+4% +$112K ﹤0.01% 3212
2025
Q4 		$2.64M Sell
120,169
-16,757
-12% -$302K ﹤0.01% 3054
2025
Q3 		$1.66M Sell
136,926
-6,348
-4% -$85.9K ﹤0.01% 3311
2025
Q2 		$2.67M Sell
143,274
-43,354
-23% -$859K ﹤0.01% 2845
2025
Q1 		$3.58M Buy
186,628
+23,014
+14% +$673K ﹤0.01% 2558
2024
Q4 		$5.89M Buy
+163,614
New +$5.53M ﹤0.01% 2217

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James Financial's TNDM Position: Q1 2026 in Review

Raymond James Financial increased its Tandem Diabetes Care (TNDM) stake by 4.3% in Q1 2026, buying an estimated $112K and bringing the position to 125,345 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

Raymond James Financial first reported a position in TNDM in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.89M in Q4 2024. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Raymond James Financial held 125,345 shares of Tandem Diabetes Care worth $2.4M as of Q1 2026.
  • Raymond James Financial bought 5,176 Tandem Diabetes Care shares in Q1 2026, an estimated $112K.
  • Tandem Diabetes Care made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3212 holding.
  • Raymond James Financial first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Tandem Diabetes Care position peaked at $5.89M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.